1Cutlip DE.Baim DS.Ho KK.et al.Stent thrombosis in the modern era:a pooled analysis of multicenter coronary stent clinical trials.Circulation,2001,103:1967-1971.
2Effects of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myorcardial infarction undergoing coronary angioplasty.The RESTORE infarction Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.Circulation,1997.96:1445-1453.
3Rukshin V.Azarbal B.Finkelstein A.et al.Effects of GP Ⅱb/Ⅲa receptor inhibitor tirofiban (aggrastat)in ex vivo canine arteriovenous shunt model of stent thrombosis.J Cardiovasc Pharmacol.2003,41:615-624.
4Rukshin V.Shan PK.Cercek B.et al.Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein Ⅱb/Ⅲa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.Circulation,2002.105:1970-1975.
5Assali AR.Sdringola S.Gbani M.et al.Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.J Invasive Cardiol,2000,12:460-463.
6Bowater SE.Doshi SN.Buller NP.Subacute stent thrombosis successfully treated with thrombolysis and glycoprotein Ⅱb/Ⅲa inhibition.Heart,2005,91:488.
7Di Pasquale P.Cannizzaro S.Paterna S.Combination of a high bolus dose of tirofiban with half-dose thrombolyties for the treatment of subacute stent thrombosis.Acta Cardiol,2005.60:61-63.
8Martinez-Rios MA.Rosas M.Gonzalez H.et al.Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction .Am J Cardiol,2004.93:280-287.
